文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

如何治疗获得性再生障碍性贫血

How I treat acquired aplastic anemia.
PubMed 文献 · Blood · 2017-01-17

获得性重型再生障碍性贫血(SAA)是罕见的血液病,免疫抑制治疗(IST)可使部分患者摆脱输血依赖或血细胞计数完全恢复,但存在无应答和晚期克隆性并发症;匹配同胞供者骨髓移植(BMT)仍是首选替代方案,年龄是IST和BMT预后的强预测因素,早期诊断、治疗及长期监测至关重要。

要点

  • IST可使部分SAA患者摆脱输血依赖或血细胞计数完全恢复。
  • 匹配同胞供者BMT是SAA的另一治疗选择,年龄是IST和BMT预后的强预测因素。
  • 早期诊断、治疗及长期监测是SAA成功治疗的关键步骤。

核心结论

  • 获得性重型再生障碍性贫血的治疗需综合考虑IST和BMT,年龄是预后强预测因素,早期诊断、治疗及长期监测至关重要。

研究设计与样本

  • 综述,未报告检索范围。

主要发现

  • 免疫抑制治疗(IST)可使部分患者摆脱输血依赖或外周血细胞计数完全恢复。
  • 生长因子可与IST联合,可能提高应答率,如近期血小板生成素类似物所示。
  • IST的问题包括无应答和晚期克隆性疾病的发生。
  • 匹配同胞供者骨髓移植(BMT)仍是缺乏匹配家族供者患者的最佳选择;无关供者主要适用于白种人患者。
  • 急性和慢性移植物抗宿主病仍是BMT的重要并发症。

临床怎么用

  • 患者年龄是IST和BMT预后的强预测因素,设计治疗策略时必须考虑。
  • 早期诊断和治疗以及长期监测仍是SAA成功治疗的关键步骤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with significant morbidity and mortality. Immune destruction of hemopoietic stem cells plays an important role in pathogenesis, as shown by successful treatment with immunosuppressive agents, leading to transfusion independence or complete recovery of peripheral blood counts in a proportion of patients. Growth factors can be combined with immunosuppressive therapy (IST) and may improve response rates, as recently shown with thrombopoietin analogs. Anabolic steroids may still play a role in combination with IST. The problem with IST is failure to respond and the development of late clonal disorders. Bone marrow transplantation (BMT) is the other therapeutic option: a matched sibling donor remains the best choice. For patients lacking a matched family donor, unrelated donors can be readily found, although mostly for patients of Caucasian origin. Other BMT options include unrelated cord blood or mismatched family donors. Acute and chronic graft-versus-host disease remain important complications of BMT. Patient age is a strong predictor of outcome for both IST and BMT, and must be considered when designing therapeutic strategies. Early diagnosis and treatment, as well as long-term monitoring, remain crucial steps for successful treatment of SAA.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017. PMID: 28096088. doi:10.1182/blood-2016-08-693481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。